nigericin has been researched along with 4-aminobenzoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boxer, MB; Burlak, C; Chataway, T; Chegini, F; Cookson, MR; Datta, D; Fisher, OS; Gai, WP; Guo, F; Hoang, QQ; Ju, S; Landeru, A; Miller, DW; Nguyen, LT; Petsko, GA; Ringe, D; Thomas, CJ; Wang, W; Wells, JA; Wu, CX; Wu, F | 1 |
| Alsaadi, M; Arkhipova, SS; Garanina, EE; Gilazieva, ZE; Hamza, S; Khaiboullina, SF; Markelova, MI; Martinova, EV; McIntyre, A; Rizvanov, AA; Tezcan, G | 1 |
2 other study(ies) available for nigericin and 4-aminobenzoic acid
| Article | Year |
|---|---|
Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.
Topics: alpha-Synuclein; Alum Compounds; Caspase 1; Cell Line, Tumor; Cell Survival; Dipeptides; Gene Expression Regulation; Humans; Inflammasomes; Interleukin-1beta; Lewy Bodies; Lipopolysaccharides; Neurons; Nigericin; para-Aminobenzoates; Protein Aggregates; RNA, Small Interfering; Signal Transduction; Vitamin K 3 | 2016 |
Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer.
Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Cell Survival; Cytokines; Dipeptides; Humans; Inflammasomes; Inflammation Mediators; MCF-7 Cells; Mitochondria; Molecular Targeted Therapy; Neoplasms; Neovascularization, Pathologic; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; para-Aminobenzoates; PC-3 Cells; Signal Transduction | 2020 |